ADO 0.00% 2.1¢ anteotech ltd

Communication to Shareholders, page-49

  1. 8,911 Posts.
    lightbulb Created with Sketch. 2574
    You've highlighted the issues we have with communication. Many times they've stated in an announcement that they'll announce when X happens but they don't follow through with it.

    I expect the Australian trial would've been completed by now ( I wasn't expecting an update as ADO often don't keep their word ) and we are now waiting on the Spanish trial to complete.

    What frustrates us is the energy division. We have no idea of battery progress except for what we can find on LinkedIn and even then it's all breadcrumbs and nothing solid
    Australian Clinical Trial
    The clinical trial underway in Victoria is ongoing and continues to progress as planned.AnteoTech will provide information on the outcome at the conclusion of the trial and on receipt of a final report. Price at posting: 6.9¢ Sentiment: Buy Disclosure: Held
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.